arrow
U

Ulrich Baumann

Hannover Medical School
H指数:51
被引数:9,763

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Plasma immune signatures can predict rejection-free survival in the first year after pediatric liver transplantation
2024-11-010
OA
Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2024-07-015
PRE
Efficacy and safety of odevixibat in patients with Alagille syndrome (ASSERT): a phase 3, double-blind randomised, placebo-controlled trial
2024-07-015
OAAI
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
2024-02-145
OA
△4-3-oxo-5β-reductase deficiency: favorable outcome in 16 patients treated with cholic acid
2023-12-072
OAAI
Genetic landscape of pediatric acute liver failure of indeterminate origin
2023-11-168
OAAI
Activated phosphoinositide 3-kinase d syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

活化的磷酸肌醇3-激酶d综合征: 来自ESID注册表的更新以及与其他自身免疫-淋巴增生先天性免疫错误的比较

2023-10-0116
OAAI
Early steroids after pediatric liver transplantation protect against T-cell-mediated rejection: Results from the ChilSFree study
2023-09-054
PRE
Gene Therapy in Patients with the Crigler-Najjar Syndrome

Crigler-najjar综合征患者的基因治疗

2023-08-1726
PRE
Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis

正在进行的odevixibat治疗进行性家族性肝内胆汁淤积症的开放标签单臂试验的中期结果

2023-08-0112
OAAI
The GAIN Registry - a New Prospective Study for Patients with Multi-organ Autoimmunity and Autoinflammation
2023-04-216
OAAI
Prospective Newborn Screening for SCID in Germany: A First Analysis by the Pediatric Immunology Working Group (API)
2023-02-2723
OAAI
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
2022-12-1413
OAAI